<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="nihpa"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3530397/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>GENOMIC ASSOCIATION ANALYSIS IDENTIFIES MULTIPLE LOCI INFLUENCING ANTIHYPERTENSIVE RESPONSE TO AN ANGIOTENSIN II RECEPTOR BLOCKER</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530397/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Hypertension"><meta name="citation_title" content="GENOMIC ASSOCIATION ANALYSIS IDENTIFIES MULTIPLE LOCI INFLUENCING ANTIHYPERTENSIVE RESPONSE TO AN ANGIOTENSIN II RECEPTOR BLOCKER"><meta name="citation_authors" content="Stephen T. Turner, Kent R. Bailey, Gary L. Schwartz, Arlene B. Chapman, High Seng Chai, Eric Boerwinkle"><meta name="citation_date" content="June 2012"><meta name="citation_issue" content="6"><meta name="citation_volume" content="59"><meta name="citation_firstpage" content="1204"><meta name="citation_doi" content="10.1161/HYP.0b013e31825b30f8"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3530397/?report=abstract"><meta name="citation_pmid" content="22566498"><meta name="DC.Title" content="GENOMIC ASSOCIATION ANALYSIS IDENTIFIES MULTIPLE LOCI INFLUENCING ANTIHYPERTENSIVE RESPONSE TO AN ANGIOTENSIN II RECEPTOR BLOCKER"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="NIH Public Access"><meta name="DC.Contributor" content="Stephen T. Turner"><meta name="DC.Contributor" content="Kent R. Bailey"><meta name="DC.Contributor" content="Gary L. Schwartz"><meta name="DC.Contributor" content="Arlene B. Chapman"><meta name="DC.Contributor" content="High Seng Chai"><meta name="DC.Contributor" content="Eric Boerwinkle"><meta name="DC.Date" content="2012 Jun"><meta name="DC.Identifier" content="10.1161/HYP.0b013e31825b30f8"><meta name="DC.Language" content="en"><meta property="og:title" content="GENOMIC ASSOCIATION ANALYSIS IDENTIFIES MULTIPLE LOCI INFLUENCING ANTIHYPERTENSIVE RESPONSE TO AN ANGIOTENSIN II RECEPTOR BLOCKER"><meta property="og:type" content="article"><meta property="og:description" content="To identify genes influencing blood pressure response to an angiotensin II receptor blocker, single nucleotide polymorphisms identified by genome-wide association analysis of the response to candesartan were validated by opposite direction associations ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530397/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><meta name="ncbi_feature" content="associated_data"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3530397/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3530397/pdf/nihms388409.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE89D15EDD53BED10000000006C6049D.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-4"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3530397%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC3530397</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html"><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Hypertension</a></span>. Author manuscript; available in PMC 2013 Jun 1.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22566498" target="pmc_ext" ref="reftype=publisher&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access"><span class="cit">Hypertension. 2012 Jun; 59(6): 1204–1211. </span></a></div><span class="fm-vol-iss-date">Published online 2012 May 7. </span> <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1161%2FHYP.0b013e31825b30f8" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1161/HYP.0b013e31825b30f8</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3530397</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS388409</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/22566498">22566498</a></div></div></div></div><h1 class="content-title">GENOMIC ASSOCIATION ANALYSIS IDENTIFIES MULTIPLE LOCI INFLUENCING ANTIHYPERTENSIVE RESPONSE TO AN ANGIOTENSIN II RECEPTOR BLOCKER</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Turner%20ST%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22566498">Stephen T. Turner</a>, <a href="/pubmed/?term=Bailey%20KR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22566498">Kent R. Bailey</a>, <a href="/pubmed/?term=Schwartz%20GL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22566498">Gary L. Schwartz</a>, <a href="/pubmed/?term=Chapman%20AB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22566498">Arlene B. Chapman</a>, <a href="/pubmed/?term=Chai%20HS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22566498">High Seng Chai</a>, and  <a href="/pubmed/?term=Boerwinkle%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22566498">Eric Boerwinkle</a></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139927411673616_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139927411673616_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139927411673616_ai" style="display:none"><div class="fm-affl" id="A1" lang="en">Division of Nephrology and Hypertension (STT, GLS), Department of Medicine, and Divisions of Biostatistics (KRB) and Biomedical Informatics (HSC) Department of Health Sciences Research, Mayo Clinic, College of Medicine, Rochester, Minnesota; Renal Division (ABC), Department of Medicine, Emory University, Atlanta, Georgia; and Human Genetics Center (EB, ASR), School of Public Health, University of Texas - Houston Health Science Center, Houston, Texas</div><div id="FN1">Correspondence to: Stephen T. Turner, M.D., Division of Nephrology and Hypertension, Mayo Clinic, 200 first Street SW, Rochester, MN 55905, Telephone: 507-284-8129; <a href="mailto:dev@null" data-email="ude.oyam@nehpets.renrut" class="oemail">ude.oyam@nehpets.renrut</a>; fax: 507-266-0824</div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm139927411673616_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=22566498" target="pmc_ext" ref="reftype=publisher&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access">Hypertension</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC3530397/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="ui-helper-clearfix" id="ui-ncbiinpagenav-heading-3">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin"><strong>1.</strong></div><div><a href="/pmc/articles/PMC3530397/bin/NIHMS388409-supplement-1.doc" data-ga-action="click_feat_suppl">NIHMS388409-supplement-1.doc</a><span style="color:gray"> (94K)</span></div><div class="small guid">GUID:&nbsp;9103EE60-AE0D-45B7-B266-308599D671C2</div></div></dd></dl></div><div id="idm139927339221744" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139927339221744title">Abstract</h2><!--article-meta--><div><p id="P1" class="p p-first-last">To identify genes influencing blood pressure response to an angiotensin II receptor blocker, single nucleotide polymorphisms identified by genome-wide association analysis of the response to candesartan were validated by opposite direction associations with the response to a thiazide diuretic, hydrochlorothiazide. 198 White and 193 African Americans with primary hypertension were sampled from opposite tertiles of the race-sex-specific distributions of age-adjusted diastolic blood pressure response to candesartan. 285 polymorphisms associated with the response to candesartan at <em>p</em>&lt;10<sup>−4</sup> in Whites. 273 of the 285 polymorphisms, which were available for analysis in a separate sample of 196 Whites, validated for opposite direction associations with the response to hydrochlorothiazide (Fisher’s <em>X</em><sup>2</sup> 1-sided <em>p</em>=0.02). Among the 273 polymorphisms, those in the chromosome 11q21 region were the most significantly associated with response to candesartan in Whites (e.g., rs11020821 near <em>FUT4</em>, <em>p</em>=8.98×10<sup>−7</sup>), had the strongest opposite direction associations with response to hydrochlorothiazide (e.g., rs3758785 in <em>GPR83</em>, <em>p</em>=7.10×10<sup>−3</sup>), and had same direction associations with response to candesartan in the 193 African Americans (e.g., rs16924603 near <em>FUT4</em>, <em>p</em>=1.52×10<sup>−2</sup>). Also notable among the 273 polymorphisms was rs11649420 on chromosome 16 in the amiloride-sensitive sodium channel subunit <em>SCNN1G</em> involved in mediating renal sodium reabsorption and maintaining blood pressure when the renin-angiotensin system is inhibited by candesartan. These results support the utility of genomewide association analyses to identify novel genes predictive of opposite direction associations with blood pressure responses to inhibitors of the renin-angiotensin and renal sodium transport systems.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Hypertension, pharmacogenetics, diuretic, blood pressure, genome</span></div></div><div id="S1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S1title">INTRODUCTION</h2><p id="P2" class="p p-first">The purpose of this study was to scan the genome for common variants, i.e., single nucleotide polymorphisms (SNPs), that predict blood pressure (BP) response to an angiotensin II receptor blocker (ARB) in White and African Americans with primary hypertension. In previous studies, the only consistently identified predictors of BP responses to antihypertensive drug treatment have been pretreatment BP level, plasma renin activity, race, and age, which together explain less than 50% of inter-individual variation in BP responses.<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155153">1</a>, <a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155171">2</a></sup> While higher pretreatment BP level is nonspecifically associated with greater BP response to all antihypertensives regardless of pharmacological class, the other established predictors of BP response are drug-class specific.<sup><a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155142">3</a></sup> Notably, the associations of renin, race, and age with BP response to ARBs and other inhibitors of the renin-angiotensin system (RAS) are directionally opposite to their associations with BP response to thiazide and other diuretics.<sup><a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155161">1</a>, <a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155150">2</a></sup></p><p id="P3" class="p p-last">Our specific objective was to identify single nucleotide polymorphisms (SNPs) that not only predict BP response to the ARB candesartan but also have directionally opposite associations with BP response to the thiazide diuretic, hydrochlorothiazide, the most commonly prescribed antihypertensive.<sup><a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155174">4</a></sup> We reasoned that such SNPs with directionally opposite effects on BP responses to drugs from different pharmacological classes would have greatest utility in individualizing antihypertensive drug therapy based on patients’ genotypes. Moreover, such SNPs could identify novel components of the vasoconstriction and volume-regulating systems that maintain BP and reciprocally oppose declines in BP when either system is inhibited by single-drug therapy.<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155170">5</a></sup></p></div><div id="S2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S2title">MATERIALS AND METHODS</h2><p id="P4" class="p p-first-last">Phenotypic data and DNA samples were collected in the Genetic Epidemiology of Responses to Antihypertensives (GERA) study between 1997 and 2007 (please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a>). Standardized drug-treatment protocols were conducted in the Centers for Transitional Science Activities (CTSA) at Emory University and the Mayo Clinic after approval by the respective institutional review committees and subjects gave informed consent.<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155181">6</a>, <a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155132">7</a></sup> A case-control sampling design was employed for genome-wide association (GWA) analyses,<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155165">8</a></sup> which contrasted good responders with poor responders sampled from opposite tertiles of the distributions of diastolic BP response to the ARB, candesartan and the thiazide diuretic, hydrochlorothiazide. For each protocol, we enrolled 300 Whites (in Rochester MN) and 300 African Americans (in Atlanta GA), who had uncomplicated primary hypertension, stage 1–2, and who were 30–59.9 years of age. Participants were instructed to discontinue previous antihypertensive medications for ≥4 weeks. Once stable elevation of the BP was achieved (diastolic BP ≥90 mmHg), the study drug was administered orally: hydrochlorothiazide 25 mg daily for four weeks or candesartan 16 mg daily for two weeks followed by 32 mg daily for four additional weeks. At the end of the drug-free and drug-treatment periods, three readings of BP were made by a trained assistant after the participant had been seated quietly for at least 5 minutes. The difference between averages of the second and third diastolic BP readings taken before and at the end of drug treatment was calculated as the primary measure of BP response.<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155177">6</a>, <a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155179">7</a></sup> A case-control sampling design was employed for genome-wide association (GWA) analyses, which contrasted good responders with poor responders sampled from opposite tertiles of the distributions of diastolic BP response to each drug.<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155141">8</a></sup> Genotypes from the Affymetrix GeneChip® Human Mapping 6.0 Array Sets were suitable for statistical analyses in the 198 White and 193 African Americans treated with candesartan. Genotypes from the Affymetrix GeneChip® Human Mapping 500K Array Sets were suitable for statistical analyses in 196 White and 194 African Americans treated with hydrochlorothiazide (please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Supplementary Methods</a>). The GWA analyses conducted within each race-drug treatment group tested each SNP for association with the diastolic BP response categories by applying the Cochran-Armitage test for trend in the proportion of good or poor responders with increase in one of the two alleles at each locus.<sup><a href="#R9" rid="R9" class=" bibr popnode">9</a>, <a href="#R10" rid="R10" class=" bibr popnode">10</a></sup> For the SNPs most significantly associated with BP response to candesartan (defined by <em>p</em>-values &lt;10<sup>−4</sup> in the primary GWA analysis in each race), we tested for validation of the SNP associations with opposite direction BP response to hydrochlorothiazide using Fisher’s method of combining the separate 1-sided <em>p</em>-values (for hydrochlorothiazide) in the same race.<sup><a href="#R11" rid="R11" class=" bibr popnode">11</a></sup> Because of linkage disequilibrium among the SNPs (and non-independence of the <em>p</em>-values), we generated the probability distribution of the <em>X</em><sup>2</sup> test statistic empirically by repetitively permuting the BP response categories for the second drug, recalculating the <em>X</em><sup>2</sup> after each permutation, and thereby generating a distribution of <em>p</em>-values for the <em>X</em><sup>2</sup> statistic under the null hypothesis (i.e., no SNP associations with BP response). Departure from the null hypothesis was tested using a 1-sided <em>X</em><sup>2</sup> test statistic in which 1-sided <em>p</em>-values from the Cochran-Armitage test for an opposite trend in the proportion of good responders to hydrochlorothiazide with increases in the number of alleles associated with good response to candesartan. In the validation setting, 1-sided <em>p</em>-values were used because of the a priori direction for each SNP effect dictated by results of the primary GWA analysis.</p></div><div id="S3" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S3title">RESULTS</h2><div id="S4" class="sec sec-first"><h3 id="S4title">Sample descriptions</h3><p id="P5" class="p p-first">By design, the 198 Whites and 193 African Americans treated with candesartan were nearly equally divided between good and poor responders and, within each response group, between men and women (<a href="/pmc/articles/PMC3530397/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Tables 1</span></a> and <a href="/pmc/articles/PMC3530397/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and2).</span></span><span>2</span></a>). Also consistent with the sampling design, the good and poor responders differed significantly in mean systolic and mean diastolic BP responses to candesartan. After race and sex-specific adjustments for age and baseline diastolic BP, the mean (±standard deviation) diastolic BP response in White good responders was −21.9±3.9 versus −4.7±5.6 mmHg in poor responders; and in African American good responders was −16.0±7.1 versus 0.3±4.4 mmHg in poor responders. Mean plasma renin activity prior to candesartan treatment was significantly greater in the good than poor responders (<em>p</em>&lt;0.0001).<sup><a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155173">7</a></sup></p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p9">Hypertensive White Americans treated with candesartan or hydrochlorothiazide</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927336307744" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="middle" align="left">Characteristic</th><th colspan="3" rowspan="1" valign="top" align="center">Candesartan treatment (N=198)</th><th colspan="3" rowspan="1" valign="top" align="center">Hydrochlorothiazide treatment (N=196)</th></tr><tr><th rowspan="1" colspan="1" valign="top" align="center">Good BP responders (N=99)</th><th rowspan="1" colspan="1" valign="top" align="center">Poor BP responders (N=99)</th><th rowspan="1" colspan="1" valign="top" align="center">Contrast <em>P</em></th><th rowspan="1" colspan="1" valign="top" align="center">Good BP responders (N=98)</th><th rowspan="1" colspan="1" valign="top" align="center">Poor BP responders (N=98)</th><th rowspan="1" colspan="1" valign="top" align="center">Contrast <em>P</em></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Women/Men</td><td rowspan="1" colspan="1" valign="top" align="center">49/50</td><td rowspan="1" colspan="1" valign="top" align="center">49/50</td><td rowspan="1" colspan="1" valign="top" align="center">1.00</td><td rowspan="1" colspan="1" valign="top" align="center">42/56</td><td rowspan="1" colspan="1" valign="top" align="center">42/56</td><td rowspan="1" colspan="1" valign="top" align="center">1.00</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Age, years</td><td rowspan="1" colspan="1" valign="top" align="center">49 ±7</td><td rowspan="1" colspan="1" valign="top" align="center">49 ±7</td><td rowspan="1" colspan="1" valign="top" align="center">0.84</td><td rowspan="1" colspan="1" valign="top" align="center">48 ±8</td><td rowspan="1" colspan="1" valign="top" align="center">49 ±7</td><td rowspan="1" colspan="1" valign="top" align="center">0.84</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">BMI, kg·m<sup>−2</sup></td><td rowspan="1" colspan="1" valign="top" align="center">29 ±4</td><td rowspan="1" colspan="1" valign="top" align="center">30 ±3</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td><td rowspan="1" colspan="1" valign="top" align="center">31 ±5</td><td rowspan="1" colspan="1" valign="top" align="center">32 ±6</td><td rowspan="1" colspan="1" valign="top" align="center">0.35</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Pretreatment SBP, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">145 ±13</td><td rowspan="1" colspan="1" valign="top" align="center">149 ±12</td><td rowspan="1" colspan="1" valign="top" align="center">0.05</td><td rowspan="1" colspan="1" valign="top" align="center">142 ±12</td><td rowspan="1" colspan="1" valign="top" align="center">143 ±13</td><td rowspan="1" colspan="1" valign="top" align="center">0.61</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Pretreatment DBP, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">95 ±5</td><td rowspan="1" colspan="1" valign="top" align="center">95 ±5</td><td rowspan="1" colspan="1" valign="top" align="center">1.00</td><td rowspan="1" colspan="1" valign="top" align="center">96 ±5</td><td rowspan="1" colspan="1" valign="top" align="center">96 ±6</td><td rowspan="1" colspan="1" valign="top" align="center">1.00</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">SBP response, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">−26.8 ±12.9</td><td rowspan="1" colspan="1" valign="top" align="center">−9.9 ±11.2</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">−17.8 ±11.0</td><td rowspan="1" colspan="1" valign="top" align="center">−3.9 ±10.9</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">DBP response, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">−22.0 ±5.2</td><td rowspan="1" colspan="1" valign="top" align="center">−4.7 ±5.5</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">−13.7 ±4.2</td><td rowspan="1" colspan="1" valign="top" align="center">1.1 ± 5.3</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Adjusted SBP response, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">−27.7 ±9.3</td><td rowspan="1" colspan="1" valign="top" align="center">−9.3 ±10.3</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">−17.9 ±8.3</td><td rowspan="1" colspan="1" valign="top" align="center">−3.5 ±9.9</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Adjusted DBP response, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">−21.9 ±3.9</td><td rowspan="1" colspan="1" valign="top" align="center">−4.7 ±5.6</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">−13.6 ±3.1</td><td rowspan="1" colspan="1" valign="top" align="center">1.20 ±4.4</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Serum potassium, mmol·L<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">4.5 ±0.3</td><td rowspan="1" colspan="1" valign="top" align="center">4.3 ±0.4</td><td rowspan="1" colspan="1" valign="top" align="center">0.003</td><td rowspan="1" colspan="1" valign="top" align="center">4.0 ±0.3</td><td rowspan="1" colspan="1" valign="top" align="center">4.0 ±0.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.90</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Plasma renin activity, ng·ml<sup>−1</sup>·hr<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.4 ±1.0</td><td rowspan="1" colspan="1" valign="top" align="center">0.7 ±0.9</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">1.3 ±0.9</td><td rowspan="1" colspan="1" valign="top" align="center">1.6 ±1.4</td><td rowspan="1" colspan="1" valign="top" align="center">0.07</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Serum aldosterone, ng·dL<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">12.1 ±6.3</td><td rowspan="1" colspan="1" valign="top" align="center">12.4 ±6.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.70</td><td rowspan="1" colspan="1" valign="top" align="center">14.5 ±6.8</td><td rowspan="1" colspan="1" valign="top" align="center">15.4 ±10.2</td><td rowspan="1" colspan="1" valign="top" align="center">0.48</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Urine aldosterone, μg·(24hr)<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">10.4 ±6.3</td><td rowspan="1" colspan="1" valign="top" align="center">11.9 ±6.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.11</td><td rowspan="1" colspan="1" valign="top" align="center">8.7 ± 4.7</td><td rowspan="1" colspan="1" valign="top" align="center">11.0 ±7.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Urine sodium, mmol·(24hr)<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">178 ±77</td><td rowspan="1" colspan="1" valign="top" align="center">181 ±89</td><td rowspan="1" colspan="1" valign="top" align="center">0.83</td><td rowspan="1" colspan="1" valign="top" align="center">159 ±66</td><td rowspan="1" colspan="1" valign="top" align="center">160 ±72</td><td rowspan="1" colspan="1" valign="top" align="center">0.92</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Urine potassium, mmol·(24hr)<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">73 ±25</td><td rowspan="1" colspan="1" valign="top" align="center">74 ±34</td><td rowspan="1" colspan="1" valign="top" align="center">0.93</td><td rowspan="1" colspan="1" valign="top" align="center">61 ±26</td><td rowspan="1" colspan="1" valign="top" align="center">71 ±29</td><td rowspan="1" colspan="1" valign="top" align="center">0.01</td></tr></tbody></table></div><div id="largeobj_idm139927336307744" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3530397/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN1"><p id="__p10" class="p p-first-last">Table entries are means ± standard deviation. SBP, systolic blood pressure; DBP, diastolic blood pressure. Adjusted SBP and DBP responses after adjustment for pretreatment blood pressure levels. <em>P</em> is significance of contrast between good and poor responders within drug-treatment group.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p11">Hypertensive African Americans treated with candesartan or hydrochlorothiazide</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927412494704" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="middle" align="left">Characteristic</th><th colspan="3" rowspan="1" valign="top" align="center">Candesartan treatment (N=193)</th><th colspan="3" rowspan="1" valign="top" align="center">Hydrochlorothiazide treatment (N=194)</th></tr><tr><th rowspan="1" colspan="1" valign="top" align="center">Good BP responders (N=99)</th><th rowspan="1" colspan="1" valign="top" align="center">Poor BP responders (N=94)</th><th rowspan="1" colspan="1" valign="top" align="center">Contrast <em>P</em></th><th rowspan="1" colspan="1" valign="top" align="center">Good BP responders (N=97)</th><th rowspan="1" colspan="1" valign="top" align="center">Poor BP responders (N= 97)</th><th rowspan="1" colspan="1" valign="top" align="center">Contrast <em>P</em></th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="left">Women/Men</td><td rowspan="1" colspan="1" valign="top" align="center">49/50</td><td rowspan="1" colspan="1" valign="top" align="center">48/46</td><td rowspan="1" colspan="1" valign="top" align="center">0.83</td><td rowspan="1" colspan="1" valign="top" align="center">50/47</td><td rowspan="1" colspan="1" valign="top" align="center">50/47</td><td rowspan="1" colspan="1" valign="top" align="center">1.00</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Age, years</td><td rowspan="1" colspan="1" valign="top" align="center">49 ±7</td><td rowspan="1" colspan="1" valign="top" align="center">49 ±7</td><td rowspan="1" colspan="1" valign="top" align="center">0.58</td><td rowspan="1" colspan="1" valign="top" align="center">47 ±6</td><td rowspan="1" colspan="1" valign="top" align="center">48 ±7</td><td rowspan="1" colspan="1" valign="top" align="center">0.52</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">BMI, kg·m<sup>−2</sup></td><td rowspan="1" colspan="1" valign="top" align="center">30 ±4</td><td rowspan="1" colspan="1" valign="top" align="center">31 ±5</td><td rowspan="1" colspan="1" valign="top" align="center">0.10</td><td rowspan="1" colspan="1" valign="top" align="center">31 ±6</td><td rowspan="1" colspan="1" valign="top" align="center">32 ±7</td><td rowspan="1" colspan="1" valign="top" align="center">0.06</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Pretreatment systolic BP, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">147 ±13</td><td rowspan="1" colspan="1" valign="top" align="center">147 ±12</td><td rowspan="1" colspan="1" valign="top" align="center">0.94</td><td rowspan="1" colspan="1" valign="top" align="center">148 ±14</td><td rowspan="1" colspan="1" valign="top" align="center">154 ±15</td><td rowspan="1" colspan="1" valign="top" align="center">0.004</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Pretreatment diastolic BP, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">96 ±5</td><td rowspan="1" colspan="1" valign="top" align="center">96 ±5</td><td rowspan="1" colspan="1" valign="top" align="center">0.86</td><td rowspan="1" colspan="1" valign="top" align="center">97 ±5</td><td rowspan="1" colspan="1" valign="top" align="center">97 ±6</td><td rowspan="1" colspan="1" valign="top" align="center">0.76</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Systolic BP response, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">−20.9 ±9.9</td><td rowspan="1" colspan="1" valign="top" align="center">0.4 ±10.5</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">−26.0 ±12.1</td><td rowspan="1" colspan="1" valign="top" align="center">−9.5 ±10.2</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Diastolic BP response, mmHg</td><td rowspan="1" colspan="1" valign="top" align="center">−16.0 ±7.2</td><td rowspan="1" colspan="1" valign="top" align="center">0.4 ±4.4</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">−18.3 ±4.9</td><td rowspan="1" colspan="1" valign="top" align="center">−0.3 ±4.4</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">SBP response, adjusted</td><td rowspan="1" colspan="1" valign="top" align="center">−20.9 ±8.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.4 ±9.9</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">−26.6 ±9.6</td><td rowspan="1" colspan="1" valign="top" align="center">−8.3 ±9.6</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">DBP response, adjusted</td><td rowspan="1" colspan="1" valign="top" align="center">−16.0 ±7.1</td><td rowspan="1" colspan="1" valign="top" align="center">0.3 ±4.4</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.001</td><td rowspan="1" colspan="1" valign="top" align="center">−18.3 ±4.2</td><td rowspan="1" colspan="1" valign="top" align="center">−0.18 ±4.3</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Serum potassium, mmol·L<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">4.1 ±0.4</td><td rowspan="1" colspan="1" valign="top" align="center">4.0 ±0.4</td><td rowspan="1" colspan="1" valign="top" align="center">0.03</td><td rowspan="1" colspan="1" valign="top" align="center">3.8 ±0.3</td><td rowspan="1" colspan="1" valign="top" align="center">3.7 ±0.3</td><td rowspan="1" colspan="1" valign="top" align="center">0.03</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Plasma renin activity, ng·ml<sup>−1</sup>·hr<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">1.0 ±2.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.4 ±1.1</td><td rowspan="1" colspan="1" valign="top" align="center">&lt;0.0001</td><td rowspan="1" colspan="1" valign="top" align="center">0.70 ±0.71</td><td rowspan="1" colspan="1" valign="top" align="center">1.12 ±1.29</td><td rowspan="1" colspan="1" valign="top" align="center">0.007</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Serum aldosterone, ng·dL<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">7.8 ±4.5</td><td rowspan="1" colspan="1" valign="top" align="center">7.6 ±4.5</td><td rowspan="1" colspan="1" valign="top" align="center">0.80</td><td rowspan="1" colspan="1" valign="top" align="center">15.8 ±8.6</td><td rowspan="1" colspan="1" valign="top" align="center">19.1 ±10.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.02</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Urine aldosterone, μg·(24hr)<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">9.2 ±8.2</td><td rowspan="1" colspan="1" valign="top" align="center">10.3 ±9.9</td><td rowspan="1" colspan="1" valign="top" align="center">0.41</td><td rowspan="1" colspan="1" valign="top" align="center">8.2 ±5.0</td><td rowspan="1" colspan="1" valign="top" align="center">10.7 ±6.9</td><td rowspan="1" colspan="1" valign="top" align="center">0.004</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Urine sodium, mmol·(24hr)<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">141 ±86</td><td rowspan="1" colspan="1" valign="top" align="center">147 ±72</td><td rowspan="1" colspan="1" valign="top" align="center">0.59</td><td rowspan="1" colspan="1" valign="top" align="center">167 ±61</td><td rowspan="1" colspan="1" valign="top" align="center">161 ±71</td><td rowspan="1" colspan="1" valign="top" align="center">0.55</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="left">Urine potassium, mmol·(24hr)<sup>−1</sup></td><td rowspan="1" colspan="1" valign="top" align="center">47 ±26</td><td rowspan="1" colspan="1" valign="top" align="center">47 ±20</td><td rowspan="1" colspan="1" valign="top" align="center">0.97</td><td rowspan="1" colspan="1" valign="top" align="center">49 ±19</td><td rowspan="1" colspan="1" valign="top" align="center">51 ±19</td><td rowspan="1" colspan="1" valign="top" align="center">0.35</td></tr></tbody></table></div><div id="largeobj_idm139927412494704" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3530397/table/T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN2"><p id="__p12" class="p p-first-last">Table entries are means ± standard deviation. SBP, systolic blood pressure; DBP, diastolic blood pressure. Adjusted SBP and DBP responses after adjustment for pretreatment blood pressure levels. <em>P</em> is significance of contrast between good and poor responders within drug-treatment group.</p></div></div></div><p id="P6" class="p p-last">The good and poor responders to hydrochlorothiazide were similar in number, gender distribution, mean age, body mass index, and pretreatment systolic and diastolic BPs to the candesartan-treated groups<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155151">8</a></sup> (shown for comparison in <a href="/pmc/articles/PMC3530397/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Tables 1</span></a> and <a href="/pmc/articles/PMC3530397/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and2).</span></span><span>2</span></a>). Mean plasma renin activity prior to hydrochlorothiazide treatment was lower in the good than poor responders (<em>p</em>≤0.07).<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155163">6</a></sup> In Whites, BP responses were greater to candesartan than to hydrochlorothiazide (<a href="/pmc/articles/PMC3530397/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>); and in African Americans, BP responses were greater to hydrochlorothiazide than to candesartan (<a href="/pmc/articles/PMC3530397/table/T2/" target="table" class="fig-table-link figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>).<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155157">6</a>, <a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155145">7</a></sup></p></div><div id="S5" class="sec"><h3 id="S5title">Genome-wide association analyses of BP response to candesartan</h3><p id="P7" class="p p-first">We used ≈2.3 million SNPs in Whites and ≈2.1 million SNPs in African Americans for the primary GWA analyses of categorically defined good versus poor BP response to candesartan in each race separately (<a href="/pmc/articles/PMC3530397/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a>). While no SNP achieved the threshold of <em>p</em>&lt;5×10<sup>−8</sup> conventionally used for genome-wide significance,<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155169">12</a></sup> the Q-Q plots in both races indicated that the number of SNP <em>p</em>-values &lt;10<sup>−4</sup> deviated above the diagonal, i.e., the expectation under the null hypothesis (H<sub>0</sub>) of no relationship between SNPs and BP response (please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Figure S1</a>). The observed number of SNP <em>p</em>-values &lt;10<sup>−4</sup> was 285 in Whites (versus 229 expected under H<sub>0</sub>) and 272 in African Americans (versus 214 expected under H<sub>0</sub>). The SNPs with <em>p</em>-values &lt;10<sup>−4</sup>, their chromosomal locations, and other descriptive information are in <a href="#SD1" rid="SD1" class=" supplementary-material">Tables S1 and S2</a> (please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3530397/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927377708640" class="figure"><a href="/pmc/articles/PMC3530397/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3530397_nihms388409f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms388409f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3530397/bin/nihms388409f1.jpg"></a></div><div id="largeobj_idm139927377708640" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3530397/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3530397/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p6">Race-specific Manhattan plots of single nucleotide polymorphism <em>p-</em>values from genome-wide association of diastolic blood pressure response to candesartan.</p></div></div></div><p id="P8" class="p p-last">Two hundred and seventy-three of the 285 SNPs identified in Whites and 264 of the 272 SNPs identified in African Americans were available for validation of opposite-direction associations with BP response to hydrochlorothiazide. In Whites, the <em>X</em><sup>2</sup> test statistic for directionally opposite SNP associations with BP response to hydrochlorothiazide had a nominal 1-sided <em>p</em>-value of 3.36×10<sup>−10</sup> and an empirically determined 1-sided <em>p</em>-value of 0.015 (upper 95% confidence limit of 0.038) based on 200 permutations of the hydrochlorothiazide BP response categories. The <em>X</em><sup>2</sup> test statistic in African Americans had a nominal 1-sided <em>p</em>-value of 0.81 and an empirically determined 1-sided <em>p</em>-value of 0.69. Therefore, only the 273 SNPs identified and validated in Whites are considered below.</p></div><div id="S6" class="sec sec-last"><h3 id="S6title">Regional SNP associations with BP responses to candesartan and hydrochlorothiazide</h3><p id="P9" class="p p-first">For the chromosomal regions identified in the primary GWA analyses of BP response to candesartan in Whites (by SNP <em>p</em>-values &lt;10<sup>−4</sup>), lead SNPs were selected that had the most significant opposite direction associations with BP response to hydrochlorothiazide (i.e., 1-sided <em>p</em>&lt;0.05) (<a href="/pmc/articles/PMC3530397/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). Adjustment for plasma renin activity slightly reduced statistical significance of the SNP associations with BP response to candesartan (<a href="/pmc/articles/PMC3530397/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). Two of the six lead SNPs were on chromosome 11, of which rs3758785 (A→G) in the G protein-coupled receptor 83 gene (<em>GPR83</em>) on 11q21 had the most significant opposite direction association with BP response to hydrochlorothiazide (1-sided <em>p</em>=7.10×10<sup>−3</sup>). For the rs3758785 GG genotype, the odds of good BP response to candesartan was more than 16-fold greater than for the AA genotype <em>and</em> the odds of good BP response to hydrochlorothiazide was almost 8-fold less than for the AA genotype (<a href="/pmc/articles/PMC3530397/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). The mean adjusted systolic BP/diastolic BP responses to candesartan were 13.7/10.5 mmHg greater for the GG than for the AA genotype, <em>and</em> the mean systolic BP/diastolic BP responses to hydrochlorothiazide were 4.7/6.3 mmHg less for the GG than for the AA genotype (<a href="/pmc/articles/PMC3530397/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>). While statistical significance of the opposite direction association with BP response to hydrochlorothiazide was maximal at rs7933335 in <em>GPR83</em> (1-sided <em>p</em>=3.33×10<sup>−3</sup>) (please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Figure S2</a>, panel b), statistical significance of the association With BP response to candesartan was maximal at rs11020821 (<em>p</em>=8.98 ×10<sup>−7</sup>) near the fucosyltransferase 4 gene (<em>FUT4</em>) (<a href="/pmc/articles/PMC3530397/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Figure 3</span></a>). Adjustment for rs11020821 near <em>FUT4</em> markedly reduced statistical significance of the association of rs3758785 in <em>GPR83</em> with BP response to candesartan (2-sided <em>p</em>=0.02) and its opposite direction association with BP response to hydrochlorothiazide (1-sided <em>p</em>= 0.05, please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Figure S3</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3530397/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927337724880" class="figure"><a href="/pmc/articles/PMC3530397/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3530397_nihms388409f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms388409f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3530397/bin/nihms388409f2.jpg"></a></div><div id="largeobj_idm139927337724880" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3530397/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3530397/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p7"><em>GPR83</em> rs3758785 genotype dependence of the odds ratios for good BP response and the mean systolic and diastolic blood pressure declines in response to each drug.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3530397/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927340015856" class="figure"><a href="/pmc/articles/PMC3530397/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3530397_nihms388409f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is nihms388409f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3530397/bin/nihms388409f3.jpg"></a></div><div id="largeobj_idm139927340015856" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3530397/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3530397/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p8">Chromosome 11q21 plot of <em>p</em> values for association of single nucleotide polymorphisms with blood pressure response to candesartan in White Americans.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p13">Lead single nucleotide polymorphisms associated with good versus poor blood pressure response to candesartan and opposite direction association with blood pressure response to hydrochlorothiazide in White Americans</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139927412603008" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1" valign="bottom" align="center">SNP</th><th colspan="3" rowspan="1" valign="bottom" align="center">Nearest Gene</th><th colspan="3" rowspan="1" valign="bottom" align="center">Candesartan treatment</th><th colspan="3" rowspan="1" valign="bottom" align="center">Hydrochlorothiazide treatment</th><th colspan="2" rowspan="1" valign="bottom" align="center">Alleles</th><th colspan="2" rowspan="1" valign="bottom" align="center">Frequency</th></tr><tr><th rowspan="1" colspan="1" valign="bottom" align="center">Chr</th><th rowspan="1" colspan="1" valign="bottom" align="center"></th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">±<em>SE</em></th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em><sup>*</sup></th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em>adj</th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>β</em></th><th rowspan="1" colspan="1" valign="bottom" align="center">±<em>SE</em></th><th rowspan="1" colspan="1" valign="bottom" align="center"><em>P</em><sup>†</sup></th><th rowspan="1" colspan="1" valign="bottom" align="center">0</th><th rowspan="1" colspan="1" valign="bottom" align="center">1</th><th rowspan="1" colspan="1" valign="bottom" align="center">C</th><th rowspan="1" colspan="1" valign="bottom" align="center">H</th></tr></thead><tbody><tr><td rowspan="1" colspan="1" valign="top" align="center">rs13059339</td><td rowspan="1" colspan="1" valign="top" align="center">3</td><td rowspan="1" colspan="1" valign="top" align="center"><em>SLC9A9</em></td><td rowspan="1" colspan="1" valign="top" align="center">0.99</td><td rowspan="1" colspan="1" valign="top" align="center">0.23</td><td rowspan="1" colspan="1" valign="top" align="center">3.30E-06</td><td rowspan="1" colspan="1" valign="top" align="center">5.553E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.37</td><td rowspan="1" colspan="1" valign="top" align="center">0.21</td><td rowspan="1" colspan="1" valign="top" align="center">3.88E-02</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">0.42</td><td rowspan="1" colspan="1" valign="top" align="center">0.39</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs3758785</td><td rowspan="1" colspan="1" valign="top" align="center">11</td><td rowspan="1" colspan="1" valign="top" align="center"><em>GPR83</em></td><td rowspan="1" colspan="1" valign="top" align="center">−1.11</td><td rowspan="1" colspan="1" valign="top" align="center">0.27</td><td rowspan="1" colspan="1" valign="top" align="center">1.39E-05</td><td rowspan="1" colspan="1" valign="top" align="center">2.044E-04</td><td rowspan="1" colspan="1" valign="top" align="center">0.58</td><td rowspan="1" colspan="1" valign="top" align="center">0.24</td><td rowspan="1" colspan="1" valign="top" align="center">7.10E-03</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.75</td><td rowspan="1" colspan="1" valign="top" align="center">0.7</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs7113572</td><td rowspan="1" colspan="1" valign="top" align="center">11</td><td rowspan="1" colspan="1" valign="top" align="center"><em>EHF</em></td><td rowspan="1" colspan="1" valign="top" align="center">−1.45</td><td rowspan="1" colspan="1" valign="top" align="center">0.38</td><td rowspan="1" colspan="1" valign="top" align="center">2.41E-05</td><td rowspan="1" colspan="1" valign="top" align="center">9.725E-05</td><td rowspan="1" colspan="1" valign="top" align="center">0.7</td><td rowspan="1" colspan="1" valign="top" align="center">0.37</td><td rowspan="1" colspan="1" valign="top" align="center">2.65E-02</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">T</td><td rowspan="1" colspan="1" valign="top" align="center">0.88</td><td rowspan="1" colspan="1" valign="top" align="center">0.9</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs2113653</td><td rowspan="1" colspan="1" valign="top" align="center">2</td><td rowspan="1" colspan="1" valign="top" align="center"><em>MYO3B</em></td><td rowspan="1" colspan="1" valign="top" align="center">1.00</td><td rowspan="1" colspan="1" valign="top" align="center">0.25</td><td rowspan="1" colspan="1" valign="top" align="center">2.57E-05</td><td rowspan="1" colspan="1" valign="top" align="center">3.743E-05</td><td rowspan="1" colspan="1" valign="top" align="center">−0.36</td><td rowspan="1" colspan="1" valign="top" align="center">0.20</td><td rowspan="1" colspan="1" valign="top" align="center">3.49E-02</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">0.49</td><td rowspan="1" colspan="1" valign="top" align="center">0.49</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs12313639</td><td rowspan="1" colspan="1" valign="top" align="center">12</td><td rowspan="1" colspan="1" valign="top" align="center"><em>SLCO1B1</em></td><td rowspan="1" colspan="1" valign="top" align="center">−6.95</td><td rowspan="1" colspan="1" valign="top" align="center">9.00</td><td rowspan="1" colspan="1" valign="top" align="center">3.22E-05</td><td rowspan="1" colspan="1" valign="top" align="center">2.225E-04</td><td rowspan="1" colspan="1" valign="top" align="center">1.71</td><td rowspan="1" colspan="1" valign="top" align="center">0.66</td><td rowspan="1" colspan="1" valign="top" align="center">1.76E-03</td><td rowspan="1" colspan="1" valign="top" align="center">C</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.03</td><td rowspan="1" colspan="1" valign="top" align="center">0.04</td></tr><tr><td rowspan="1" colspan="1" valign="top" align="center">rs11649420</td><td rowspan="1" colspan="1" valign="top" align="center">16</td><td rowspan="1" colspan="1" valign="top" align="center"><em>SCNN1G</em></td><td rowspan="1" colspan="1" valign="top" align="center">−1.09</td><td rowspan="1" colspan="1" valign="top" align="center">0.30</td><td rowspan="1" colspan="1" valign="top" align="center">9.41E-05</td><td rowspan="1" colspan="1" valign="top" align="center">7.818E-04</td><td rowspan="1" colspan="1" valign="top" align="center">0.57</td><td rowspan="1" colspan="1" valign="top" align="center">0.28</td><td rowspan="1" colspan="1" valign="top" align="center">2.00E-02</td><td rowspan="1" colspan="1" valign="top" align="center">A</td><td rowspan="1" colspan="1" valign="top" align="center">G</td><td rowspan="1" colspan="1" valign="top" align="center">0.21</td><td rowspan="1" colspan="1" valign="top" align="center">0.22</td></tr></tbody></table></div><div id="largeobj_idm139927412603008" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3530397/table/T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="TFN3"><p id="__p14" class="p p-first-last">SNP, single nucleotide polymorphism; Chr, chromosome; <em>β</em>, logistic regression coefficient; <em>SE</em>, standard error of the logistic regression coefficient.</p></div><div id="TFN4"><p id="__p15" class="p p-first-last">Alleles: 0, reference allele; 1, alternative allele. Frequency of reference allele: C, among candesartan treated group; H, among hydrochlorothiazide treated group.</p></div><div id="TFN5"><sup>*</sup>, 2-sided p-value;</div><div id="TFN6"><p id="__p17" class="p p-first-last"><em>P</em>adj, adjusted for plasma renin activity;</p></div><div id="TFN7"><sup>†</sup>1-sided p-value.</div><div id="TFN8"><p id="__p19" class="p p-first-last">The logistic regression coefficients (<em>β</em>s) represent log-of-the-odds of good blood pressure response associated with each copy of the alternative allele.</p></div></div></div><p id="P10">Additional SNPs in the chromosome 11q21 region identified in Whites also validated for same direction associations with BP response to candesartan in the African American sample (1-sided <em>p</em>&lt;0.05). Two of these SNPs were in <em>GPR83</em> (rs3758786 and rs3758789); one was near <em>MRE11A</em> (rs12270338); and two near <em>FUT4</em> (rs16924603 and rs16912567), of which rs16924603 was most significantly associated (1-sided <em>p</em>=1.52×10<sup>−2</sup>) (please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>, <a href="/pmc/articles/PMC3530397/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a>, panel c). In the previous African American sample of good and poor BP responders to hydrochlorothiazide,<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155138">8</a></sup> the chromosome 11q21 region was independently identified by a lead SNP rs2851582 in the angiomotin like 1 gene (<em>AMOTL1</em>) that was primarily associated with BP response to hydrochlorothiazide (2-sided <em>p</em>=5.37×10<sup>−5</sup>) and also validated for directionally opposite association with BP response to candesartan in the present African American sample (1-sided <em>p</em>=3.61×10<sup>−3</sup>) (please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Figure S2</a>, panel d). In both races, there was linkage disequilibrium among the SNPs in the GPR83-to-<em>FUT4</em> region but not with SNPs in <em>AMOTL1</em> (please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Figure S4</a>).</p><p id="P11" class="p p-last">Other lead SNPs discovered and validated in Whites included rs11649420 in the gene encoding the γ-subunit (<em>SCNN1G</em>) of the amiloride-sensitive sodium channel (<a href="/pmc/articles/PMC3530397/table/T3/" target="table" class="fig-table-link figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>). For the rs11649420 GG genotype, the odds of good BP response to candesartan was three-fold greater than for the combined AA+AG group <em>and</em> the odds of good BP response to hydrochlorothiazide was two-fold less than for the combined AA+AG group (please see <a href="http://hyper.aha.journals.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://hyper.aha.journals.org</a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Figure S5</a>). The mean adjusted systolic BP/diastolic BP responses to candesartan were 7.0/5.5 mmHg greater for the GG than for the AA+AG group, <em>and</em> the mean systolic BP/diastolic BP responses to hydrochlorothiazide were 4.5/2.5 mmHg less for the GG than for the AA genotype.</p></div></div><div id="S7" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S7title">DISCUSSION</h2><p id="P12" class="p p-first">We sought to identify SNPs associated with directionally opposite BP responses to candesartan and hydrochlorothiazide because of their greater potential utility in personalizing antihypertensive drug therapy than SNPs that only predict response to a single drug or the same response to drugs from multiple classes. Pursuit of this objective was also motivated by the knowledge that established predictors of antihypertensive drug responses have directionally opposite associations with BP responses to diuretics and inhibitors of the renin-angiotensin system.<sup><a href="#R10" rid="R10" class=" bibr popnode">10</a>, <a href="#R11" rid="R11" class=" bibr popnode">11</a></sup> These inverse relationships reflect the complementary effects of angiotensin-mediated arterial constriction and intra-arterial volume to maintain BP, which reciprocally oppose declines in BP when either system is inhibited.<sup><a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155147">5</a></sup> Accordingly, we hypothesized that alternative alleles of SNPs associated with BP response to candesartan may have directionally opposite associations with BP response to hydrochlorothiazide.</p><p id="P13">Our analytical approach was also guided by the opposite direction associations of known predictors with BP responses to candesartan and hydrochlorothiazide.<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155137">6</a>, <a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155140">7</a></sup> Since none of the large number of SNPs tested for associations with BP response to candesartan achieved the <em>p</em>-value threshold for genome-wide significance,<sup><a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155182">12</a></sup> we guarded against false positives by requiring that the SNPs discovered to be most strongly associated with BP response to candesartan also validated for opposite direction associations with BP response to hydrochlorothiazide in separate samples of each race. In lieu of replicate same-race, same-drug-treated samples, this validation approach was employed because of differences between races in frequencies of the marker SNPs,<sup><a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155156">8</a></sup> linkage disequilibrium of the markers with functional variants,<sup><a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155126">13</a></sup> and differences in variances of the BP responses between races.<sup><a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155131">6</a>, <a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155144">7</a></sup> Within each race, the number of SNPs strongly associated with BP response to candesartan exceeded what was expected by chance alone, but the identified SNPs differed between races. Only the SNPs discovered in Whites also validated for opposite direction associations with BP response to hydrochlorothiazide.</p><p id="P14">Obvious candidates to influence BP response to a drug are genes that encode components of the BP-regulating systems targeted by the drug.<sup><a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155136">14</a></sup> Additional logical candidates are genes encoding components of the counterregulatory systems opposing the decline in BP following drug administration. From this perspective, notable among the SNPs discovered and validated in Whites were SNPs in the gene encoding the the γ-subunit (<em>SCNN1G</em>) of the amiloride-sensitive sodium channel involved in distal renal tubular sodium reabsorption. Gain-of-function mutations in <em>SCNN1G</em> cause Liddle’s syndrome, a rare familial form of low-renin, sodium-volume dependent hypertension that responds to diuretic therapy with amiloride.<sup><a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155130">15</a></sup> In contrast, treatment of low-renin, sodium-volume dependent hypertension with inhibitors of the renin-angiotensin system has been associated with opposite-direction pressor responses.<sup><a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155134">16</a></sup> We have previously reported that <em>SCNN1G</em> SNPs (rs5723 and rs5729) in strong linkage disequilibrium with the lead SNP, rs11649420 (<em>r</em><sup>2</sup>=0.87), were associated with BP response to hydrochlorothiazide.<sup><a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155175">17</a></sup> Our present findings that <em>SCNN1G</em> SNPs were among those most strongly associated with BP response to candesartan <em>and</em> had opposite direction associations with BP response to hydrochlorothiazide is consistent with the counterregulatory effect of renal sodium reabsorption to maintain intra-arterial volume and oppose the decline in BP following inhibition of the renin-angiotensin system with candesartan.<sup><a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155149">18</a></sup></p><p id="P15">Only three previous studies have reported polymorphisms in candidate genes to predict BP responses to ARBs.<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155139">19</a>–<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155152">21</a></sup> In the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial, 49 adults with stage I–II hypertension were treated with the irbesartan for three months and 74 SNPs were genotyped in 25 genes encoding regulators of volume, vasoconstriction, and drug metabolism.<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155162">22</a></sup> The SNPs found to be associated with BP response were in the genes encoding aldosterone synthase<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155135">20</a>, <a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155129">23</a></sup> (<em>CYP11B2</em>), angiotensinogen,<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155160">22</a></sup> angiotensin converting enzyme,<sup><a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155155">19</a>, <a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155159">22</a></sup> endothelin receptor type B,<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155164">22</a></sup> endothelial nitric oxide synthase,<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155178">22</a></sup> apolipoprotein(a),<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155128">22</a></sup> hepatic lipase C,<sup><a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155133">22</a></sup> and a cytochrome P450 enzyme<sup><a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155148">21</a>, <a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155167">24</a></sup> (<em>CYP2C9</em>). In the other candidate gene studies of ARB responses, associations were also reported for the same <em>CYP11B2</em> polymorphism (−344 C/T) with BP response to candesartan<sup><a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155127">20</a></sup> and the same <em>CYP2C9</em> polymorphism (*1/*2/*3) with BP response to losartan.<sup><a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155185">21</a></sup> However, the alleles associated with greater BP lowering different from those found in the SILVHIA trial. Associations of polymorphisms in several of the candidate genes in the SILVHIA trial have also been reported with BP response to diuretic therapy.<sup><a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155143">25</a>–<a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155125">29</a></sup> However, the alleles associated with greater BP response to diuretic therapy were not consistent across studies, nor were the alternative alleles consistently associated with greater BP response to inhibitors of the renin-angiotensin system.<sup><a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155168">30</a>, <a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155154">31</a></sup> Thus, none of the previously reported candidate gene associations with BP responses was replicated across independent samples. Of the previously investigated candidate genes, in the present study only SNPs in <em>SCNN1G</em> were strongly associated with BP response to candesartan and validated for opposite direction associations with BP response to hydrochlorothiazide.</p><p id="P16">While GWA analyses provide an unbiased opportunity to discover novel variants not previously implicated or suspected to influence BP responses, biologic mechanisms that may account for the other identified SNP associations with BP response to candesartan are not readily apparent. Variation in three of the five other identified genes has been associated with hypertension-related phenotypes: rs1371924 in <em>SLC9A9</em>, which encodes a sodium/hydrogen exchanger,<sup><a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_313463427">32</a></sup> was associated with arterial stiffness in the Framingham Heart Study 100K Project;<sup><a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155176">33</a></sup> rs4149014 in the promoter of <em>SLCO1B1</em>, which encodes an organic anion transporter implicated in statin-induced myopathy,<sup><a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155146">34</a></sup> was associated with increased risk for primary hypertension in Chinese Uyghurs;<sup><a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155124">35</a></sup> and <em>MYO3B</em>, which encodes a class III myosin, actin-dependent motor protein expressed in the kidney,<sup><a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155180">36</a></sup> has been implicated as a potential candidate for a rare syndrome including renal abnormalities and hypertension.<sup><a href="#R37" rid="R37" class=" bibr popnode">37</a></sup> The other two identified genes, <em>EHF</em> and <em>GPR83</em>, are 64Mbp apart on chromosome 11 and have no reported associations with hypertension-related phenotypes. <em>EHF</em> encodes a transcriptional activator implicated in epithelial cell differentiation and proliferation;<sup><a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155158">38</a></sup> and <em>GPR83</em> encodes an orphan G protein-coupled receptor 83 that may be a neuropeptide Y receptor. <sup><a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155172">39</a></sup> Variations in plasma renin activity did not account for the lead SNPs’ associations with BP response to candesartan. Considerable additional work will be necessary to replicate the identified novel associations of variation in these genes with opposite direction BP responses to candesartan and hydrochlorothiazide.</p><p id="P17" class="p">Our approach to validation of SNPs associated with BP response to candesartan by requiring opposite direction associations with BP response to hydrochlorothiazide has limitations. Although pretreatment plasma renin activity, race, and age conform to this pattern of inverse associations, other characteristics, e.g., pretreatment BP level, predict same direction BP response to all drugs<sup><a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155184">40</a></sup> or may only predict BP response to a single class of drugs.<sup><a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155166">2</a></sup> In Whites, our analyses may not have identified SNPs with same-direction associations with BP response to both candesartan and hydrochlorothiazide or SNPs only associated with BP response to one of the drugs. In African Americans, some of the SNPs that failed to validate for opposite direction associations with BP response to hydrochlorothiazide may still be true predictors of BP response to candesartan.</p><div id="S8" class="sec sec-last"><h3 id="S8title">Perspective</h3><p id="P18" class="p p-first-last">Replication across multiple, well-powered, independent samples has become the gold standard for reliability of genetic associations.<sup><a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_291155183">41</a></sup> Because predictors of greater BP response to candesartan are expected also to be associated with lesser BP response to hydrochlorothiazide, we validated the SNPs most strongly associated with BP response to candesartan by testing for opposite direction associations with BP response to hydrochlorothiazide in another sample from the same race. This approach to validating reliability of antihypertensive pharmacogenetic associations is not only feasible in lieu of multiple same-race, same-drug-treated samples but also widely applicable since the majority of antihypertensive drugs target the renin-angiotensin or renal sodium transport systems. Moreover, genetic predictors associated with opposite direction BP responses to drugs that inhibit vasoconstriction and volume-regulating systems maintaining BP hold promise for individualizing antihypertensive drug therapy and identifying novel targets for antihypertensive drug therapy.</p></div></div><div id="unreferenced-ft" class="tsec sec headless whole_rhythm"><div class="unreferenced">​
                    <div class="boxed-text-box whole_rhythm hide-overflow" id="BX1"><div class="caption"><h3 id="idm139927338062752title">NOVELTY AND SIGNIFICANCE</h3></div><div class="sec" id="S13"><h3 id="S13title">What is new?</h3><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
max-label-size=0
--><li><p id="P20">Genome-wide association analysis of BP to an angiotensin II receptor blocker</p></li><li><p id="P21">SNPs associated with BP response to candesartan validate for opposite direction association with BP response to hydrochlorothiazide</p></li></ul></div><div class="sec" id="S14"><h3 id="S14title">What is relevant?</h3><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
max-label-size=0
--><li><p id="P23">Such SNPs can identify components of the renin-angiotensin and renal sodium transport systems that reciprocally oppose BP declines when either system is inhibited.</p></li><li><p id="P24">Predictors of directionally opposite BP responses to drugs from different pharmacological classes have greatest utility in individualizing antihypertensive drug therapy.</p></li></ul></div><div class="sec" id="S15"><h3 id="S15title">Summary</h3><ul class="unordered" style="list-style-type:disc"><!--
list-behavior=unordered
prefix-word=
mark-type=disc
max-label-size=0
--><li><p id="P26">SNPs in novel genes predictive of opposite direction associations with BP responses to the vasoconstriction and volume-retaining systems maintaining BP may provide new targets for antihypertensive drug therapy.</p></li></ul></div></div></div></div><div id="S10" class="tsec sec"><a id="supplementary-material-sec"></a><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S10title">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="d35e873"><a href="/pmc/articles/PMC3530397/bin/NIHMS388409-supplement-1.doc" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(94K, doc)</sup></div></div></div><div id="S11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="S11title">Acknowledgments</h2><div class="sec"><p id="__p1">Technical assistance of Zhiying Wang, Meagan Grove, Jodie Van De Rostyne, Jeremy Palbicki.</p><p id="__p2"><strong>SOURCES OF FUNDING</strong></p><p id="__p3">Supported by <a id="__tag_789989501" class="tag_hotlink" href="/nuccore/HL074735" ref="/nuccore/HL074735"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"HL074735","term_id":"1051638336","term_text":"HL074735"}}</span>HL074735</a>, <a id="__tag_789989502" class="tag_hotlink" href="/nuccore/HL053335" ref="/nuccore/HL053335"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"HL053335","term_id":"1051590831","term_text":"HL053335"}}</span>HL053335</a>, and Mayo Foundation.</p></div></div><div id="idm139927340460864" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139927340460864title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"></p><p id="__p4" class="p p-first"><strong>DISCLOSURES</strong></p><p id="__p5" class="p p-last">None.</p><p></p></div></div><div id="idm139927340459360" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139927340459360title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="R1">1. <span class="element-citation">Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, Anderson RJ. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of veterans affairs cooperative study group on antihypertensive agents. <span><span class="ref-journal">JAMA. </span>1998;<span class="ref-vol">280</span>:1168–1172.</span> [<a href="/pubmed/9777817" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Age-race+subgroup+compared+with+renin+profile+as+predictors+of+blood+pressure+response+to+antihypertensive+therapy.+Department+of+veterans+affairs+cooperative+study+group+on+antihypertensive+agents&amp;author=RA+Preston&amp;author=BJ+Materson&amp;author=DJ+Reda&amp;author=DW+Williams&amp;author=RJ+Hamburger&amp;volume=280&amp;publication_year=1998&amp;pages=1168-1172&amp;pmid=9777817&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R2">2. <span class="element-citation">Turner ST, Schwartz GL, Chapman AB, Beitelshees AL, Gums JG, Cooper-DeHoff RM, Boerwinkle E, Johnson JA, Bailey KR. Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension. <span><span class="ref-journal">Am J Hypertens. </span>2010;<span class="ref-vol">23</span>:1014–1022.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2941699/">PMC free article</a>]</span> [<a href="/pubmed/20725057" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hypertens&amp;title=Plasma+renin+activity+predicts+blood+pressure+responses+to+beta-blocker+and+thiazide+diuretic+as+monotherapy+and+add-on+therapy+for+hypertension&amp;author=ST+Turner&amp;author=GL+Schwartz&amp;author=AB+Chapman&amp;author=AL+Beitelshees&amp;author=JG+Gums&amp;volume=23&amp;publication_year=2010&amp;pages=1014-1022&amp;pmid=20725057&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R3">3. <span class="element-citation">Laragh JH, Lamport B, Sealey J, Alderman MH. Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment. <span><span class="ref-journal">Hypertension. </span>1988;<span class="ref-vol">12</span>:223–226.</span> [<a href="/pubmed/3049337" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Diagnosis+ex+juvantibus.+Individual+response+patterns+to+drugs+reveal+hypertension+mechanisms+and+simplify+treatment&amp;author=JH+Laragh&amp;author=B+Lamport&amp;author=J+Sealey&amp;author=MH+Alderman&amp;volume=12&amp;publication_year=1988&amp;pages=223-226&amp;pmid=3049337&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R4">4. <span class="element-citation">Reilly RF, Peixoto AJ, Desir GV. The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2010;<span class="ref-vol">5</span>:1893–1903.</span> [<a href="/pubmed/20798254" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+J+Am+Soc+Nephrol&amp;title=The+evidence-based+use+of+thiazide+diuretics+in+hypertension+and+nephrolithiasis&amp;author=RF+Reilly&amp;author=AJ+Peixoto&amp;author=GV+Desir&amp;volume=5&amp;publication_year=2010&amp;pages=1893-1903&amp;pmid=20798254&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R5">5. <span class="element-citation">Laragh JH, Sealey JE. The plasma renin test reveals the contribution of body sodium-volume content (v) and renin-angiotensin (r) vasoconstriction to long-term blood pressure. <span><span class="ref-journal">Am J Hypertens. </span>2011;<span class="ref-vol">24</span>:1164–1180.</span> [<a href="/pubmed/21938070" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hypertens&amp;title=The+plasma+renin+test+reveals+the+contribution+of+body+sodium-volume+content+(v)+and+renin-angiotensin+(r)+vasoconstriction+to+long-term+blood+pressure&amp;author=JH+Laragh&amp;author=JE+Sealey&amp;volume=24&amp;publication_year=2011&amp;pages=1164-1180&amp;pmid=21938070&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R6">6. <span class="element-citation">Chapman AB, Schwartz GL, Boerwinkle E, Turner ST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. <span><span class="ref-journal">Kidney Int. </span>2002;<span class="ref-vol">61</span>:1047–1055.</span> [<a href="/pubmed/11849460" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Predictors+of+antihypertensive+response+to+a+standard+dose+of+hydrochlorothiazide+for+essential+hypertension&amp;author=AB+Chapman&amp;author=GL+Schwartz&amp;author=E+Boerwinkle&amp;author=ST+Turner&amp;volume=61&amp;publication_year=2002&amp;pages=1047-1055&amp;pmid=11849460&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R7">7. <span class="element-citation">Canzanello VJ, Baranco-Pryor E, Rahbari-Oskoui F, Schwartz GL, Boerwinkle E, Turner ST, Chapman AB. Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension. <span><span class="ref-journal">Am J Hypertens. </span>2008;<span class="ref-vol">21</span>:61–66.</span> [<a href="/pubmed/18091745" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hypertens&amp;title=Predictors+of+blood+pressure+response+to+the+angiotensin+receptor+blocker+candesartan+in+essential+hypertension&amp;author=VJ+Canzanello&amp;author=E+Baranco-Pryor&amp;author=F+Rahbari-Oskoui&amp;author=GL+Schwartz&amp;author=E+Boerwinkle&amp;volume=21&amp;publication_year=2008&amp;pages=61-66&amp;pmid=18091745&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R8">8. <span class="element-citation">Turner ST, Bailey KR, Fridley BL, Chapman AB, Schwartz GL, Chai HS, Sicotte H, Kocher JP, Rodin AS, Boerwinkle E. Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic. <span><span class="ref-journal">Hypertension. </span>2008;<span class="ref-vol">52</span>:359–365.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2692710/">PMC free article</a>]</span> [<a href="/pubmed/18591461" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Genomic+association+analysis+suggests+chromosome+12+locus+influencing+antihypertensive+response+to+thiazide+diuretic&amp;author=ST+Turner&amp;author=KR+Bailey&amp;author=BL+Fridley&amp;author=AB+Chapman&amp;author=GL+Schwartz&amp;volume=52&amp;publication_year=2008&amp;pages=359-365&amp;pmid=18591461&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R9">9. <span class="element-citation">Cochran WG. Some methods for strengthening the common chi-square tests. <span><span class="ref-journal">Biometrics. </span>1954;<span class="ref-vol">10</span>:417–451.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biometrics&amp;title=Some+methods+for+strengthening+the+common+chi-square+tests&amp;author=WG+Cochran&amp;volume=10&amp;publication_year=1954&amp;pages=417-451&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R10">10. <span class="element-citation">Armitage P. Tests for linear trends in proportions and frequencies. <span><span class="ref-journal">Biometrics. </span>1955;<span class="ref-vol">11</span>:375–386.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biometrics&amp;title=Tests+for+linear+trends+in+proportions+and+frequencies&amp;author=P+Armitage&amp;volume=11&amp;publication_year=1955&amp;pages=375-386&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R11">11. <span class="element-citation">Fisher RA.  <span class="ref-journal">Statistical methods for research workers.</span> Edinburgh, London: Oliver and Boyd; 1925.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Statistical+methods+for+research+workers&amp;author=RA+Fisher&amp;publication_year=1925&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R12">12. <span class="element-citation">Risch N, Merikangas K. The future of genetic studies of complex human diseases. <span><span class="ref-journal">Science. </span>1996;<span class="ref-vol">273</span>:1516–1517.</span> [<a href="/pubmed/8801636" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+future+of+genetic+studies+of+complex+human+diseases&amp;author=N+Risch&amp;author=K+Merikangas&amp;volume=273&amp;publication_year=1996&amp;pages=1516-1517&amp;pmid=8801636&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R13">13. <span class="element-citation">Ioannidis JP, Ntzani EE, Trikalinos TA. ‘Racial’ differences in genetic effects for complex diseases. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:1312–1318.</span> [<a href="/pubmed/15543147" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=‘Racial’+differences+in+genetic+effects+for+complex+diseases&amp;author=JP+Ioannidis&amp;author=EE+Ntzani&amp;author=TA+Trikalinos&amp;volume=36&amp;publication_year=2004&amp;pages=1312-1318&amp;pmid=15543147&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R14">14. <span class="element-citation">Turner ST, Schwartz GL, Chapman AB, Hall WD, Boerwinkle E. Antihypertensive pharmacogenetics: Getting the right drug into the right patient. <span><span class="ref-journal">J Hypertens. </span>2001;<span class="ref-vol">19</span>:1–11.</span> [<a href="/pubmed/11204288" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hypertens&amp;title=Antihypertensive+pharmacogenetics:+Getting+the+right+drug+into+the+right+patient&amp;author=ST+Turner&amp;author=GL+Schwartz&amp;author=AB+Chapman&amp;author=WD+Hall&amp;author=E+Boerwinkle&amp;volume=19&amp;publication_year=2001&amp;pages=1-11&amp;pmid=11204288&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R15">15. <span class="element-citation">Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP. Hypertension caused by a truncated epithelial sodium channel gamma subunit: Genetic heterogeneity of liddle syndrome. <span><span class="ref-journal">Nat Genet. </span>1995;<span class="ref-vol">11</span>:76–82.</span> [<a href="/pubmed/7550319" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Hypertension+caused+by+a+truncated+epithelial+sodium+channel+gamma+subunit:+Genetic+heterogeneity+of+liddle+syndrome&amp;author=JH+Hansson&amp;author=C+Nelson-Williams&amp;author=H+Suzuki&amp;author=L+Schild&amp;author=R+Shimkets&amp;volume=11&amp;publication_year=1995&amp;pages=76-82&amp;pmid=7550319&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R16">16. <span class="element-citation">Alderman MH, Cohen HW, Sealey JE, Laragh JH. Pressor responses to antihypertensive drug types. <span><span class="ref-journal">Am J Hypertens. </span>2010;<span class="ref-vol">23</span>:1031–1037.</span> [<a href="/pubmed/20725055" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hypertens&amp;title=Pressor+responses+to+antihypertensive+drug+types&amp;author=MH+Alderman&amp;author=HW+Cohen&amp;author=JE+Sealey&amp;author=JH+Laragh&amp;volume=23&amp;publication_year=2010&amp;pages=1031-1037&amp;pmid=20725055&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R17">17. <span class="element-citation">Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. Wnk1 kinase polymorphism and blood pressure response to a thiazide diuretic. <span><span class="ref-journal">Hypertension. </span>2005;<span class="ref-vol">46</span>:758–765.</span> [<a href="/pubmed/16172412" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Wnk1+kinase+polymorphism+and+blood+pressure+response+to+a+thiazide+diuretic&amp;author=ST+Turner&amp;author=GL+Schwartz&amp;author=AB+Chapman&amp;author=E+Boerwinkle&amp;volume=46&amp;publication_year=2005&amp;pages=758-765&amp;pmid=16172412&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R18">18. <span class="element-citation">Gavras H, Brunner HR, Laragh JH, Sealey JE, Gavras I, Vukovich RA. An angiotensin converting enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. <span><span class="ref-journal">N Engl J Med. </span>1974;<span class="ref-vol">291</span>:817–821.</span> [<a href="/pubmed/4371298" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=An+angiotensin+converting+enzyme+inhibitor+to+identify+and+treat+vasoconstrictor+and+volume+factors+in+hypertensive+patients&amp;author=H+Gavras&amp;author=HR+Brunner&amp;author=JH+Laragh&amp;author=JE+Sealey&amp;author=I+Gavras&amp;volume=291&amp;publication_year=1974&amp;pages=817-821&amp;pmid=4371298&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R19">19. <span class="element-citation">Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Hagg A, Lind L. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin ii receptor type 1 antagonist treatment in hypertensive patients. <span><span class="ref-journal">J Hypertens. </span>2001;<span class="ref-vol">19</span>:1783–1787.</span> [<a href="/pubmed/11593098" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hypertens&amp;title=Angiotensin+converting+enzyme+gene+polymorphism+predicts+blood+pressure+response+to+angiotensin+ii+receptor+type+1+antagonist+treatment+in+hypertensive+patients&amp;author=L+Kurland&amp;author=H+Melhus&amp;author=J+Karlsson&amp;author=T+Kahan&amp;author=K+Malmqvist&amp;volume=19&amp;publication_year=2001&amp;pages=1783-1787&amp;pmid=11593098&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R20">20. <span class="element-citation">Ortlepp JR, Hanrath P, Mevissen V, Kiel G, Borggrefe M, Hoffmann R. Variants of the cyp11b2 gene predict response to therapy with candesartan. <span><span class="ref-journal">Eur J Pharmacol. </span>2002;<span class="ref-vol">445</span>:151–152.</span> [<a href="/pubmed/12065207" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Pharmacol&amp;title=Variants+of+the+cyp11b2+gene+predict+response+to+therapy+with+candesartan&amp;author=JR+Ortlepp&amp;author=P+Hanrath&amp;author=V+Mevissen&amp;author=G+Kiel&amp;author=M+Borggrefe&amp;volume=445&amp;publication_year=2002&amp;pages=151-152&amp;pmid=12065207&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R21">21. <span class="element-citation">Sekino K, Kubota T, Okada Y, Yamada Y, Yamamoto K, Horiuchi R, Kimura K, Iga T. Effect of the single cyp2c9*3 allele on pharmacokinetics and pharmacodynamics of losartan in healthy japanese subjects. <span><span class="ref-journal">Eur J Clin Pharmacol. </span>2003;<span class="ref-vol">59</span>:589–592.</span> [<a href="/pubmed/14504849" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Clin+Pharmacol&amp;title=Effect+of+the+single+cyp2c9*3+allele+on+pharmacokinetics+and+pharmacodynamics+of+losartan+in+healthy+japanese+subjects&amp;author=K+Sekino&amp;author=T+Kubota&amp;author=Y+Okada&amp;author=Y+Yamada&amp;author=K+Yamamoto&amp;volume=59&amp;publication_year=2003&amp;pages=589-592&amp;pmid=14504849&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R22">22. <span class="element-citation">Liljedahl U, Karlsson J, Melhus H, Kurland L, Lindersson M, Kahan T, Nystrom F, Lind L, Syvanen AC. A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response. <span><span class="ref-journal">Pharmacogenetics. </span>2003;<span class="ref-vol">13</span>:7–17.</span> [<a href="/pubmed/12544508" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenetics&amp;title=A+microarray+minisequencing+system+for+pharmacogenetic+profiling+of+antihypertensive+drug+response&amp;author=U+Liljedahl&amp;author=J+Karlsson&amp;author=H+Melhus&amp;author=L+Kurland&amp;author=M+Lindersson&amp;volume=13&amp;publication_year=2003&amp;pages=7-17&amp;pmid=12544508&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R23">23. <span class="element-citation">Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman P, Nystrom F, Hagg A, Lind L. Aldosterone synthase (cyp11b2) −344 c/t polymorphism is related to antihypertensive response: Result from the swedish irbesartan left ventricular hypertrophy investigation versus atenolol (silvhia) trial. <span><span class="ref-journal">Am J Hypertens. </span>2002;<span class="ref-vol">15</span>:389–393.</span> [<a href="/pubmed/12022239" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hypertens&amp;title=Aldosterone+synthase+(cyp11b2)+−344+c/t+polymorphism+is+related+to+antihypertensive+response:+Result+from+the+swedish+irbesartan+left+ventricular+hypertrophy+investigation+versus+atenolol+(silvhia)+trial&amp;author=L+Kurland&amp;author=H+Melhus&amp;author=J+Karlsson&amp;author=T+Kahan&amp;author=K+Malmqvist&amp;volume=15&amp;publication_year=2002&amp;pages=389-393&amp;pmid=12022239&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R24">24. <span class="element-citation">Hallberg P, Karlsson J, Kurland L, Lind L, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Melhus H. The cyp2c9 genotype predicts the blood pressure response to irbesartan: Results from the swedish irbesartan left ventricular hypertrophy investigation vs atenolol (silvhia) trial. <span><span class="ref-journal">J Hypertens. </span>2002;<span class="ref-vol">20</span>:2089–2093.</span> [<a href="/pubmed/12359989" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hypertens&amp;title=The+cyp2c9+genotype+predicts+the+blood+pressure+response+to+irbesartan:+Results+from+the+swedish+irbesartan+left+ventricular+hypertrophy+investigation+vs+atenolol+(silvhia)+trial&amp;author=P+Hallberg&amp;author=J+Karlsson&amp;author=L+Kurland&amp;author=L+Lind&amp;author=T+Kahan&amp;volume=20&amp;publication_year=2002&amp;pages=2089-2093&amp;pmid=12359989&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R25">25. <span class="element-citation">Jiang X, Sheng HH, Lin G, Li J, Lu XZ, Cheng YL, Huang J, Xiao HS, Zhan YY. Effect of renin-angiotensin-aldosterone system gene polymorphisms on blood pressure response to antihypertensive treatment. <span><span class="ref-journal">Chin Med J (Engl) </span>2007;<span class="ref-vol">120</span>:782–786.</span> [<a href="/pubmed/17531119" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chin+Med+J+(Engl)&amp;title=Effect+of+renin-angiotensin-aldosterone+system+gene+polymorphisms+on+blood+pressure+response+to+antihypertensive+treatment&amp;author=X+Jiang&amp;author=HH+Sheng&amp;author=G+Lin&amp;author=J+Li&amp;author=XZ+Lu&amp;volume=120&amp;publication_year=2007&amp;pages=782-786&amp;pmid=17531119&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R26">26. <span class="element-citation">Li Y, Zhou Y, Yang P, Niu JQ, Wu Y, Zhao DD, Wu SL. Interaction of ace and cyp11b2 genes on blood pressure response to hydrochlorothiazide in han chinese hypertensive patients. <span><span class="ref-journal">Clin Exp Hypertens. </span>2011;<span class="ref-vol">33</span>:141–146.</span> [<a href="/pubmed/21269061" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Hypertens&amp;title=Interaction+of+ace+and+cyp11b2+genes+on+blood+pressure+response+to+hydrochlorothiazide+in+han+chinese+hypertensive+patients&amp;author=Y+Li&amp;author=Y+Zhou&amp;author=P+Yang&amp;author=JQ+Niu&amp;author=Y+Wu&amp;volume=33&amp;publication_year=2011&amp;pages=141-146&amp;pmid=21269061&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R27">27. <span class="element-citation">Wu SL, Li Y, Liu KJ, Hou GS, Wang JJ, Wu YT, Song SM. [association of polymorphisms in ace and cyp11b2 genes with antihypertensive effects of hydrochlorothiazide] <span><span class="ref-journal">Zhonghua Xin Xue Guan Bing Za Zhi. </span>2005;<span class="ref-vol">33</span>:595–598.</span> [<a href="/pubmed/16080804" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Zhonghua+Xin+Xue+Guan+Bing+Za+Zhi&amp;title=[association+of+polymorphisms+in+ace+and+cyp11b2+genes+with+antihypertensive+effects+of+hydrochlorothiazide]&amp;author=SL+Wu&amp;author=Y+Li&amp;author=KJ+Liu&amp;author=GS+Hou&amp;author=JJ+Wang&amp;volume=33&amp;publication_year=2005&amp;pages=595-598&amp;pmid=16080804&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R28">28. <span class="element-citation">Sciarrone MT, Stella P, Barlassina C, Manunta P, Lanzani C, Bianchi G, Cusi D. Ace and alpha-adducin polymorphism as markers of individual response to diuretic therapy. <span><span class="ref-journal">Hypertension. </span>2003;<span class="ref-vol">41</span>:398–403.</span> [<a href="/pubmed/12623934" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hypertension&amp;title=Ace+and+alpha-adducin+polymorphism+as+markers+of+individual+response+to+diuretic+therapy&amp;author=MT+Sciarrone&amp;author=P+Stella&amp;author=C+Barlassina&amp;author=P+Manunta&amp;author=C+Lanzani&amp;volume=41&amp;publication_year=2003&amp;pages=398-403&amp;pmid=12623934&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R29">29. <span class="element-citation">Turner ST, Chapman AB, Schwartz GL, Boerwinkle E. Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. <span><span class="ref-journal">Am J Hypertens. </span>2003;<span class="ref-vol">16</span>:834–839.</span> [<a href="/pubmed/14553962" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hypertens&amp;title=Effects+of+endothelial+nitric+oxide+synthase,+alpha-adducin,+and+other+candidate+gene+polymorphisms+on+blood+pressure+response+to+hydrochlorothiazide&amp;author=ST+Turner&amp;author=AB+Chapman&amp;author=GL+Schwartz&amp;author=E+Boerwinkle&amp;volume=16&amp;publication_year=2003&amp;pages=834-839&amp;pmid=14553962&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R30">30. <span class="element-citation">Turner ST, Schwartz GL. Gene markers and antihypertensive therapy. <span><span class="ref-journal">Curr Hypertens Rep. </span>2005;<span class="ref-vol">7</span>:21–30.</span> [<a href="/pubmed/15683583" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr+Hypertens+Rep&amp;title=Gene+markers+and+antihypertensive+therapy&amp;author=ST+Turner&amp;author=GL+Schwartz&amp;volume=7&amp;publication_year=2005&amp;pages=21-30&amp;pmid=15683583&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R31">31. <span class="element-citation">Mellen PB, Herrington DM. Pharmacogenomics of blood pressure response to antihypertensive treatment. <span><span class="ref-journal">J Hypertens. </span>2005;<span class="ref-vol">23</span>:1311–1325.</span> [<a href="/pubmed/15942450" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hypertens&amp;title=Pharmacogenomics+of+blood+pressure+response+to+antihypertensive+treatment&amp;author=PB+Mellen&amp;author=DM+Herrington&amp;volume=23&amp;publication_year=2005&amp;pages=1311-1325&amp;pmid=15942450&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R32">32. <span class="element-citation">Ohgaki R, van ISC, Matsushita M, Hoekstra D, Kanazawa H. Organellar na+/h+ exchangers: Novel players in organelle ph regulation and their emerging functions. <span><span class="ref-journal">Biochemistry (Mosc) </span>2011;<span class="ref-vol">50</span>:443–450.</span> [<a href="/pubmed/21171650" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry+(Mosc)&amp;title=Organellar+na+/h++exchangers:+Novel+players+in+organelle+ph+regulation+and+their+emerging+functions&amp;author=R+Ohgaki&amp;author=ISC+van&amp;author=M+Matsushita&amp;author=D+Hoekstra&amp;author=H+Kanazawa&amp;volume=50&amp;publication_year=2011&amp;pages=443-450&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R33">33. <span class="element-citation">Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, Hwang SJ, Vasan RS, Mitchell GF. Framingham heart study 100k project: Genome-wide associations for blood pressure and arterial stiffness. <span><span class="ref-journal">BMC Med Genet. </span>2007;<span class="ref-vol">8 </span>(Suppl 1):S3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1995621/">PMC free article</a>]</span> [<a href="/pubmed/17903302" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Med+Genet&amp;title=Framingham+heart+study+100k+project:+Genome-wide+associations+for+blood+pressure+and+arterial+stiffness&amp;author=D+Levy&amp;author=MG+Larson&amp;author=EJ+Benjamin&amp;author=C+Newton-Cheh&amp;author=TJ+Wang&amp;volume=8+&amp;issue=Suppl+1&amp;publication_year=2007&amp;pages=S3&amp;pmid=17903302&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R34">34. <span class="element-citation">Link E, Parish S, Armitage J, Bowman L, Heath S, Matsuda F, Gut I, Lathrop M, Collins R. Slco1b1 variants and statin-induced myopathy--a genomewide study. <span><span class="ref-journal">N Engl J Med. </span>2008;<span class="ref-vol">359</span>:789–799.</span> [<a href="/pubmed/18650507" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Slco1b1+variants+and+statin-induced+myopathy--a+genomewide+study&amp;author=E+Link&amp;author=S+Parish&amp;author=J+Armitage&amp;author=L+Bowman&amp;author=S+Heath&amp;volume=359&amp;publication_year=2008&amp;pages=789-799&amp;pmid=18650507&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R35">35. <span class="element-citation">Lin R, Wang X, Zhou W, Fu W, Wang Y, Huang W, Jin L. Association of polymorphisms in the solute carrier organic anion transporter family member 1b1 gene with essential hypertension in the uyghur population. <span><span class="ref-journal">Ann Hum Genet. </span>2011;<span class="ref-vol">75</span>:305–311.</span> [<a href="/pubmed/21309757" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Hum+Genet&amp;title=Association+of+polymorphisms+in+the+solute+carrier+organic+anion+transporter+family+member+1b1+gene+with+essential+hypertension+in+the+uyghur+population&amp;author=R+Lin&amp;author=X+Wang&amp;author=W+Zhou&amp;author=W+Fu&amp;author=Y+Wang&amp;volume=75&amp;publication_year=2011&amp;pages=305-311&amp;pmid=21309757&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R36">36. <span class="element-citation">Dose AC, Burnside B. A class iii myosin expressed in the retina is a potential candidate for bardet-biedl syndrome. <span><span class="ref-journal">Genomics. </span>2002;<span class="ref-vol">79</span>:621–624.</span> [<a href="/pubmed/11991710" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=A+class+iii+myosin+expressed+in+the+retina+is+a+potential+candidate+for+bardet-biedl+syndrome&amp;author=AC+Dose&amp;author=B+Burnside&amp;volume=79&amp;publication_year=2002&amp;pages=621-624&amp;pmid=11991710&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R37">37. <span class="element-citation">Waters AM, Beales PL.  <span class="ref-journal">Bardet-biedl syndrome.</span> 1993.  <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Bardet-biedl+syndrome&amp;author=AM+Waters&amp;author=PL+Beales&amp;publication_year=1993&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R38">38. <span class="element-citation">Kleinbaum LA, Duggan C, Ferreira E, Coffey GP, Buttice G, Burton FH. Human chromosomal localization, tissue/tumor expression, and regulatory function of the ets family gene ehf. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>1999;<span class="ref-vol">264</span>:119–126.</span> [<a href="/pubmed/10527851" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Human+chromosomal+localization,+tissue/tumor+expression,+and+regulatory+function+of+the+ets+family+gene+ehf&amp;author=LA+Kleinbaum&amp;author=C+Duggan&amp;author=E+Ferreira&amp;author=GP+Coffey&amp;author=G+Buttice&amp;volume=264&amp;publication_year=1999&amp;pages=119-126&amp;pmid=10527851&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R39">39. <span class="element-citation">De Moerlooze L, Williamson J, Liners F, Perret J, Parmentier M. Cloning and chromosomal mapping of the mouse and human genes encoding the orphan glucocorticoid-induced receptor (gpr83) <span><span class="ref-journal">Cytogenet Cell Genet. </span>2000;<span class="ref-vol">90</span>:146–150.</span> [<a href="/pubmed/11060465" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cytogenet+Cell+Genet&amp;title=Cloning+and+chromosomal+mapping+of+the+mouse+and+human+genes+encoding+the+orphan+glucocorticoid-induced+receptor+(gpr83)&amp;author=L+De+Moerlooze&amp;author=J+Williamson&amp;author=F+Liners&amp;author=J+Perret&amp;author=M+Parmentier&amp;volume=90&amp;publication_year=2000&amp;pages=146-150&amp;pmid=11060465&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R40">40. <span class="element-citation">Gill JS, Zezulka AV, Beevers DG, Davies P. Relation between initial blood pressure and its fall with treatment. <span><span class="ref-journal">Lancet. </span>1985;<span class="ref-vol">1</span>:567–569.</span> [<a href="/pubmed/2857912" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Relation+between+initial+blood+pressure+and+its+fall+with+treatment&amp;author=JS+Gill&amp;author=AV+Zezulka&amp;author=DG+Beevers&amp;author=P+Davies&amp;volume=1&amp;publication_year=1985&amp;pages=567-569&amp;pmid=2857912&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="R41">41. <span class="element-citation">McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. <span><span class="ref-journal">Nat Rev Genet. </span>2008;<span class="ref-vol">9</span>:356–369.</span> [<a href="/pubmed/18398418" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Genet&amp;title=Genome-wide+association+studies+for+complex+traits:+Consensus,+uncertainty+and+challenges&amp;author=MI+McCarthy&amp;author=GR+Abecasis&amp;author=LR+Cardon&amp;author=DB+Goldstein&amp;author=J+Little&amp;volume=9&amp;publication_year=2008&amp;pages=356-369&amp;pmid=18398418&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3530397&amp;issue-id=217573&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#ui-ncbiinpagenav-heading-3">Associated Data</a></li><li><a href="#idm139927339221744title">Abstract</a></li><li><a href="#S1title">INTRODUCTION</a></li><li><a href="#S2title">MATERIALS AND METHODS</a></li><li><a href="#S3title">RESULTS</a></li><li><a href="#S7title">DISCUSSION</a></li><li><a href="#S10title">Supplementary Material</a></li><li><a href="#S11title">Acknowledgments</a></li><li><a href="#idm139927340460864title">Footnotes</a></li><li><a href="#idm139927340459360title">References</a></li></ul></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3530397/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3530397/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3530397/pdf/nihms388409.pdf">PDF (1.3M)</a></li> | <li><a href="#" data-citationid="PMC3530397" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3530397%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3530397%2F&amp;text=GENOMIC%20ASSOCIATION%20ANALYSIS%20IDENTIFIES%20MULTIPLE%20LOCI%20INFLUENCING%20ANTIHYPERTENSIVE%20RESPONSE%20TO%20AN%20ANGIOTENSIN%20II%20RECEPTOR%20BLOCKER" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3530397%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="22566498" data-aiid="3530397" data-aid="3530397" data-iid="217573" data-domainid="319" data-domain="nihpa" data-accid="PMC3530397" data-md5="95d882e07d846382600fa7dd46817ce8"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T08:54:46-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE89D15EDD53BED10000000006C6049D&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3530397%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3530397/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>